
AI-generated summary
Advanced Micro Devices (AMD) announced its third-quarter results on Tuesday, with data center sales surging and its Q4 revenue forecast exceeding analysts' expectations. CEO Su Zifeng expects revenue to grow by more than 80% in 2027, and 80% of sales next year will come from data centers. Intel released disappointing earnings last week, sending its stock price down the most in decades.
Advanced Micro Devices (AMD) announced its third-quarter results and latest financial forecast on Tuesday (3rd). Driven by a surge in data center sales, it is expected to grow faster than expected in 2027. The relevant report effectively refuted people's concerns that the AI boom is losing momentum and eased investor concerns after rival Intel released its outlook last week, pushing AMD's stock price to rise by 8% in after-hours trading.
Comprehensive foreign media reports, Supermicro's financial report shows that this year's Q3 data center revenue soared 97%, reaching a record high of US$8.55 billion (approximately NT$281.380 billion), exceeding the previously expected US$8.2 billion (approximately NT$269.861 billion). Q4 revenue is expected to be US$17 billion (approximately NT$559.469 billion), plus or minus 3%, which easily exceeds analysts’ average forecast of US$16.3 billion (approximately NT$536.433 billion).
CEO Su Zifeng said that the company expects overall revenue to grow by more than 80% in 2027, which is higher than the 77% growth expected by analysts. Su told analysts that 80% of sales next year will come from data centers, which will drive most of the revenue and profit growth. It can be seen that data center business, CPU business and data center AI business all have demand. Judging from the speed and pace of growth, we have been preparing for this in the past few years.
The outlook provides new evidence that spending on AI is sustainable, reassuring anxious investors. Shares of chipmakers and other technology companies have been hammered in recent weeks on worries about a bubble in the AI infrastructure industry.
Jacob Bourne, an analyst at eMarketer, a market research company, pointed out in the report that AMD’s earnings are not only a test of its own performance, but also a test of the entire AI industry. These results will be encouraging for investors as they increasingly focus on AI spending and returns due to the recent sell-off in the technology and semiconductor industries.
AMD's outlook, coupled with strong forecasts from server maker Super Micro Computer, fueled after-hours gains for AI equipment makers and cloud service providers.
Under Su's leadership, AMD has become one of the most important suppliers of core processors and computers for AI facilities, supporting a host of new services. Despite the recent market turmoil, AMD's stock price has more than doubled this year, and the company's market value reached US$1 trillion (approximately NT$32.91 trillion) in September.
Growth in the data center business has helped AMD offset a downturn in the PC market, where rising memory chip costs have slowed production and curbed user demand. Intel, AMD's main rival in the field, suffered its worst share price drop in decades after it posted disappointing earnings last week.
As AMD continues to achieve great results, sales today are twice what they were two years ago. AMD also outperformed long-time rival Intel in the central processing unit (CPU) market. However, AMD still lags far behind Huida in terms of AI accelerators used to train and run AI models.
AI outlook — possibilities, not facts
AMD’s revenue will grow by more than 80% in 2027
Possible · Within months
Next year 80% of sales will come from data centers
Possible · Within months
The Hong Kong International Financial Leaders Investment Summit was held from November 2 to 4. Vice Premier Ho Lifeng delivered a video speech, saying that Hong Kong's governance and revitalization situation continued to consolidate. The country's "15th Five-Year Plan" has made arrangements to support Hong Kong in consolidating and improving its competitive advantages. He also hoped that Hong Kong would give full play to the advantages of "one country, two systems" and consolidate its status as an international financial center.

In the first three quarters, the added value of my country's large-scale high-tech manufacturing industry increased by 14.3% year-on-year. More than 13,000 advanced smart factories and more than 500 excellence-level smart factories have been built. There are 8,336 green factories. 80 national advanced manufacturing clusters cover 26 provinces. Experts believe that adhering to the direction of intelligence, greenness, and integration will stabilize the fundamentals of the manufacturing industry.

The U.S. midterm elections are counting, and the Republican Party is likely to suffer a crushing defeat. Nasdaq futures plunged more than 1.86%, and Taiwanese stocks turned from red to black, fluctuating nearly 800 points. According to legal analysis, if Trump is defeated, the short-term market may be worried about increasing AI supervision, and technology and AI stocks will be under pressure. Foreign investors have sold more than Taiwanese stocks by 1.2 trillion in October, and funds may return to technology stocks after the election.
PC manufacturers such as HP, Asus, and Acer are transferring some of their production capacity from Southeast Asia back to mainland China. The AI boom has led to a tight supply of memory chips and a sharp increase in material costs. China's complete electronics industry chain, efficient production capabilities and manufacturing talent advantages have become prominent. Data from the Ministry of Commerce show that in the first three quarters of this year, more than 6,300 foreign-funded companies made additional investments in China, and investment in high-tech industries increased by 33.8%.

Nittobo's stock price plunged nearly 7%, dragging Taiwan Glass (1802)'s stock price from red to black. After opening at 69.6 yuan, the selling pressure came out. As of 9:38, it fell 0.3 yuan to 67.4 yuan, with a trading volume of more than 110,000 contracts. The legal person advises investors not to chase high prices and keep cash in hand to maintain profits.

Danish biotech company Genmab's three cancer drugs petosemtamab, Rina-S and Epkinly have successively achieved positive results in phase 3 clinical trials. The combination of petosemtamab and Keytruda reduced the risk of death in head and neck cancer patients by 50%, driving the company's stock price to double in just three months, and rose 48% in a single week last week.